Trial Information

Summary: URCC U1902: A phase II/III randomized, controlled clinical trial of ginger for nausea caused by chemotherapy for cancer

Ginger will be taken by mouth and be given in addition to the current best medication for nausea.

The purpose of this study is to determine if ginger capsules given in addition to the current best medication to manage nausea caused by chemotherapy, can provide even better control of that nausea.

  • Diagnosis of cancer and be scheduled to receive at least 3 more cycles of chemotherapy
  • Concurrent radiation is not allowed
  • No clinical evidence of current or impending bowel obstruction

Contact:

Janeen V. Bazan, Oncology Research Nurse Coordinator
Sherman Health Systems
934 Center Street
Elgin, IL 60120
Telephone: 847-429-2907
Fax: 847-429-3071
Email:

Profile Page: Sherman Health Systems, Elgin, IL

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:44:48 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA